ART-TG is a partner of the IRIS network of excellence (RHU) aiming to develop new generations...

.

..of gene therapies for severe immune deficiencies. In this consortium, ART-TG will bring its expertise on the quality control of genetically modified cells.

RHU IRIS : Gene therapy for inherited monogenic diseases of the immune system. Read the press release.